{"name":"Noah Rosenberg, MD","slug":"noah-rosenberg-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Neo-Synalar Cream","genericName":"Neo-Synalar Cream","slug":"neo-synalar-cream","indication":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)","status":"marketed"}]}],"pipeline":[{"name":"Neo-Synalar Cream","genericName":"Neo-Synalar Cream","slug":"neo-synalar-cream","phase":"marketed","mechanism":"Neo-Synalar Cream is a topical corticosteroid that reduces inflammation and suppresses immune responses in the skin.","indications":["Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOLVcwT0UtTFZuYTAtTnNMUDdoSGZtT0ZRbkREcnN3aEJzalM5Yms4aHlhdDF1eXlOTV9SNDRabzk4aDdUYWlGMkRkOE5hZEs4NDB3TTJoMGVxUFBEMjB6ZDNTbG12MXc5M0tJVVBkR2FSbGxvQlRucXVRTlFETkJ4U3B2dVAzaUpRcFhCdnFB?oc=5","date":"2025-03-26","type":"pipeline","source":"Yahoo Finance","summary":"Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer - Yahoo Finance","headline":"Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPdjZEVXlrOWQ1a3J2eko4aVNMX1N5RFhiX1lWRWdiNTlHUnZSc2UxYkRaVGRDbFhmWGhseEpDTW90bW4wVHpiM2IzUklNVGNmaXloQ1lWWnM1czJ2VXVQckI0dVdmYWd1YVRhOWdjVF9LT3ZhWnpWeW5fOXc0azRmMVBoMDJ1R2ZrNjdPMEYydFdTVkpDeW1Td1hmQ3dXOTBP?oc=5","date":"2018-08-03","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Cell Medica names Kite’s European chief as CEO - Fierce Biotech","headline":"Chutes & Ladders—Cell Medica names Kite’s European chief as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBMQnVWR2ptNmVrZ2hTclpsNEJiQXJkSHQ4cEhQNzFza2ZQWlJ4SGJPekJQWC02QV9hbTZtemhiV29JM3NDdHl1d3ZibUlmcnA0TDNKQ0FzaEtRSnlF?oc=5","date":"2017-05-15","type":"pipeline","source":"PNAS","summary":"Linkage disequilibrium matches forensic genetic records to disjoint genomic marker sets - PNAS","headline":"Linkage disequilibrium matches forensic genetic records to disjoint genomic marker sets","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}